Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Nuclear Medicine

  Free Subscription


09.06.2025

1 AJNR Am J Neuroradiol
1 Ann Nucl Med
3 Brain
36 Clin Nucl Med
1 IEEE Trans Med Imaging
9 J Nucl Med
7 Nucl Med Commun
2 Phys Med Biol
1 PLoS One
3 Semin Nucl Med


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. DAGHER SA, Learned KO, Dagher R, Wang JR, et al
    [(18)F]-FDG Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma following BRAF-Targeted Therapy.
    AJNR Am J Neuroradiol. 2025;46:1260-1267.
    PubMed         Abstract available


    Ann Nucl Med

  2. ZHANG X, Nakajima K, Acampa W, Assante R, et al
    Establishment of a (123)I-meta-iodobenzylguanidine normal database for D-SPECT using Japanese and Italian data.
    Ann Nucl Med. 2025 Jun 2. doi: 10.1007/s12149-025-02061.
    PubMed         Abstract available


    Brain

  3. PRANGE S, Metereau E, Klinger H, Huddlestone M, et al
    Serotonergic dysfunction in patients with impulse control disorders in Parkinson's disease.
    Brain. 2025;148:2108-2121.
    PubMed         Abstract available

  4. SAINBURG LE, Englot DJ, Morgan VL
    The impact of resective epilepsy surgery on the brain network: evidence from post-surgical imaging.
    Brain. 2025 Jan 24:awaf026. doi: 10.1093.
    PubMed         Abstract available

  5. CHAUVEAU L, Landeau B, Dautricourt S, Turpin AL, et al
    Anterior-temporal network hyperconnectivity is key to Alzheimer's disease: from ageing to dementia.
    Brain. 2025 Jan 15:awaf008. doi: 10.1093.
    PubMed         Abstract available


    Clin Nucl Med

  6. SADEQ A, Fathallah W, Baqer A, Agrawal K, et al
    alphavbeta6 Imaging With 68Ga-Trivehexin PET/CT in Pituitary Macroadenoma.
    Clin Nucl Med. 2025 Jun 4. doi: 10.1097/RLU.0000000000005950.
    PubMed         Abstract available

  7. RAEISI N, Saber Tanha A, Soltani E, Aryana K, et al
    Targeted Detection of Recurrence and Metastasis in Adrenocortical Carcinoma: A Novel Approach Using 99mTc-FAPI-46 SPECT/CT Imaging.
    Clin Nucl Med. 2025;50:e435-e436.
    PubMed         Abstract available

  8. SABER TANHA A, Rabani F, Raeisi N, Shafiei S, et al
    Concealed in Plain Sight: Revelation of Spina Bifida Occulta on 99mTc-MDP Whole-Body Bone Scan and SPECT/CT.
    Clin Nucl Med. 2025;50:e430-e432.
    PubMed         Abstract available

  9. RAEISI N, Saber Tanha A, Aryana K, Jabbari Nooghabi A, et al
    Pulmonary Lymphangitis Carcinomatosis in Rapid Progressive Recurrent Pheochromocytoma: A Case Exhibiting the Peer Diagnostic Value of 99mTc-FAPI-46 and 99mTc-HYNIC-Octreotide Scans.
    Clin Nucl Med. 2025;50:e417-e418.
    PubMed         Abstract available

  10. BELGE BILGIN G, Bilgin C, Powell GM, Thorpe MP, et al
    Tumor Thrombus Associated With Locally Recurrent Osteosarcoma on [18F] FDG PET/CT.
    Clin Nucl Med. 2025;50:655-657.
    PubMed         Abstract available

  11. LU C, Ou X
    An Impressive Widespread Sarcoid Myopathy in 18F-FDG PET/CT.
    Clin Nucl Med. 2025;50:649-651.
    PubMed         Abstract available

  12. KURONUMA K, Miyagi A, Takahashi K, Mukai T, et al
    Utility of Lung Volume-normalized SUV on Lung Perfusion SPECT in Patients With Chronic Thromboembolic Pulmonary Hypertension.
    Clin Nucl Med. 2025;50:623-630.
    PubMed         Abstract available

  13. TAO X, Zhang Q, Li N, Wang S, et al
    Prognostic Value of 18F-FDG PET/CT in Neoadjuvant PD-1 Inhibitor-treated NSCLC: A Five-year Follow-up Study.
    Clin Nucl Med. 2025;50:577-587.
    PubMed         Abstract available

  14. YEH SH, Lin YS, Lee WJ, Chang WY, et al
    A Landmark Multiyear Study of Alzheimer Disease: Integrating [18F]FEPPA PET Imaging With 12 Clinical Assessments for Comprehensive Disease Profiling.
    Clin Nucl Med. 2025;50:557-567.
    PubMed         Abstract available

  15. WANG Q, Xu S, Chen X
    Potential Pancreatic Pitfall of 68 Ga-FAPI-04.
    Clin Nucl Med. 2025;50:673-674.
    PubMed         Abstract available

  16. YAO Q, Zhang B, Zhang F, Zhang X, et al
    Redistribution of Intraspinal and Muscular 18 F-FDG Uptake after the Epidural Electrical Stimulation Treatment in Spinal Cord Injury Individuals.
    Clin Nucl Med. 2025;50:e401-e406.
    PubMed         Abstract available

  17. ZHAO Y, Chen C, Zhang H, Peng P, et al
    Hepatic Venous Hemangioma Mimics Acetate-Positive Hepatocellular Carcinoma.
    Clin Nucl Med. 2025;50:644-646.
    PubMed         Abstract available

  18. GHALYOUN L, Palard-Novello X, Mouheb M, Delaleux A, et al
    Detection of Cerebral Ischemia in Bone Scan.
    Clin Nucl Med. 2025;50:e449-e450.
    PubMed         Abstract available

  19. JUNG MK, Ha EJ, Kim JH, Kang YS, et al
    Prediction of Cerebral Hyperperfusion Syndrome After Combined Bypass Surgery in Moyamoya Disease Using Hemodynamic and Clinical Data.
    Clin Nucl Med. 2025;50:588-595.
    PubMed         Abstract available

  20. SABER TANHA A, Rafiei Z, Raeisi N, Tayyebi Meibodi N, et al
    99m Tc-PSMA Scintigraphy of Subcutaneous Angiolipoma.
    Clin Nucl Med. 2025;50:e428-e429.
    PubMed         Abstract available

  21. HE J, Dong A
    Multifocal FDG Uptake of the Breasts Caused by Autologous Fat Injection for Breast Augmentation.
    Clin Nucl Med. 2025;50:670-672.
    PubMed         Abstract available

  22. GANESAN H, Madivanane V, Dhayalane K, Sainath R, et al
    A Case of McCune Albright Syndrome With Rare Extensive Polyostotic Fibrous Dysplasia.
    Clin Nucl Med. 2025;50:e433-e434.
    PubMed         Abstract available

  23. JIANG Y, Tian Y, He Y
    68 Ga-FAPI-04 Outperforms 18 F-FDG in Detecting Lesions for Primary Leiomyosarcoma of Bone : A Rare Case.
    Clin Nucl Med. 2025;50:e425-e427.
    PubMed         Abstract available

  24. SAHAFI P, Samadi MH, Sadeghi R
    Atlas of Renal Scintigraphy With Emphasis on SPECT/CT Imaging: Pearls and Pitfalls.
    Clin Nucl Med. 2025 Jun 6. doi: 10.1097/RLU.0000000000005907.
    PubMed         Abstract available

  25. WANG J, Li Y, Doss M, Yu JQM, et al
    Different Appearances of Esophageal Squamous Cell Carcinoma in 18F-PSMA PET/CT Versus 18F-FDG PET/CT.
    Clin Nucl Med. 2025 Jun 6. doi: 10.1097/RLU.0000000000005722.
    PubMed         Abstract available

  26. DUARTE PS, Moraes RDR, Costa EAD, Sapienza MT, et al
    Sessile Serrated Adenoma Plus Lipoid Pneumonia Mimicking a Colon Cancer With Pulmonary Metastatic Lesions on 18F-FDG PET/CT.
    Clin Nucl Med. 2025 Jun 6. doi: 10.1097/RLU.0000000000005744.
    PubMed         Abstract available

  27. MOREAU A, Lhuillier R, Rivory J, Durand A, et al
    Bifocal Insulinoma Detected With 68Ga-Exendin PET/CT and Treated With Endoscopic Ultrasound-guided Radiofrequency Ablation: Toward a Gold-Standard Management?
    Clin Nucl Med. 2025 Jun 6. doi: 10.1097/RLU.0000000000005774.
    PubMed         Abstract available

  28. LAWAL IO, Li X, Sakach EA, Farley CR, et al
    Negative 18F-FES PET/CT Despite Estrogen Receptor Positivity by Immunohistochemistry.
    Clin Nucl Med. 2025 Jun 6. doi: 10.1097/RLU.0000000000006023.
    PubMed         Abstract available

  29. LIU H, Gong W, Ji Y, Xu T, et al
    68Ga-FAP-2286 PET/CT Imaging of Nuclear Protein of the Testis Midline Carcinoma in the Lung.
    Clin Nucl Med. 2025 Jun 6. doi: 10.1097/RLU.0000000000006020.
    PubMed         Abstract available

  30. LIU G, Wang S, Du B, Li Y, et al
    PSMA and FDG PET/CT Findings for Differential Diagnosis of Bone Metastasis in a Patient With Synchronous Small-cell Lung Cancer and Prostate Cancer.
    Clin Nucl Med. 2025 Jun 5. doi: 10.1097/RLU.0000000000005915.
    PubMed         Abstract available

  31. SUN Z, Jiang X, Fu G, Sun S, et al
    The Characteristics of Prostate Mucinous Adenocarcinoma Visualized by 68Ga-PSMA, 68Ga-FAPI, and 18F-FDG PET/CT.
    Clin Nucl Med. 2025 Jun 5. doi: 10.1097/RLU.0000000000006004.
    PubMed         Abstract available

  32. VERMA P, Reddy MM, Lila A, Basu S, et al
    Localization of Parathyroid Adenoma With 68Ga-NODAGA-RGD PET/CT and Demonstration of "Metabolic Superscan" With Lincoln Sign and Costochondral Junction Beading: A Potential Clinical Application.
    Clin Nucl Med. 2025 Jun 5. doi: 10.1097/RLU.0000000000006013.
    PubMed         Abstract available

  33. TAN X, Liu Y, Wang Y, Zhu Y, et al
    Atypical Lymphoid Hyperplasia of the Liver on FDG PET/CT.
    Clin Nucl Med. 2025 Jun 5. doi: 10.1097/RLU.0000000000006002.
    PubMed         Abstract available

  34. JIANG C, Zhou W, Ye H
    Primary Solitary Rib Lymphoma on FDG PET/CT.
    Clin Nucl Med. 2025 Jun 5. doi: 10.1097/RLU.0000000000005814.
    PubMed         Abstract available

  35. LIU Y, Lin X, Zhou N, Cui Y, et al
    Deficiency of 68Ga-FAPI-04 PET/CT Compared With 18F-FDG PET/CT in Staging Metastatic Paraganglioma: A Case Report.
    Clin Nucl Med. 2025 Jun 5. doi: 10.1097/RLU.0000000000006007.
    PubMed         Abstract available

  36. GLANTSCHNIG L, Reitsam NG, Kleffel T, Lapa C, et al
    [18F]FDG PET/CT in Primary Angiosarcoma of the Thyroid.
    Clin Nucl Med. 2025 Jun 4. doi: 10.1097/RLU.0000000000006012.
    PubMed         Abstract available

  37. RAEISI N, Saber Tanha A, Mosavi Z, Mousavian A, et al
    Phosphaturic Mesenchymal Tumor in the Foot Detected by 99mTc-FAPI-46 SPECT/CT and 18F-FDG PET/CT.
    Clin Nucl Med. 2025 Jun 4. doi: 10.1097/RLU.0000000000006016.
    PubMed         Abstract available

  38. SABER TANHA A, Raeisi N, Jafari Zarrin Ghabaei F, Ghorbani H, et al
    Superior Performance of 99mTc-FAPI SPECT/CT Compared With 99mTc-PSMA Scintigraphy in the Initial Staging of Prostate Cancer: A Case Report.
    Clin Nucl Med. 2025 Jun 4. doi: 10.1097/RLU.0000000000006005.
    PubMed         Abstract available

  39. BARTHOLOMA M, Rosar F, Burgard C, Maus S, et al
    Novel 64Cu-labeled Trimeric PSMA Ligand Unequivocally Identifies Local Recurrence of Prostate Cancer Ambiguously Imaged by 18F-DCFPyL PSMA PET/CT.
    Clin Nucl Med. 2025 Jun 4. doi: 10.1097/RLU.0000000000006010.
    PubMed         Abstract available

  40. LONG T, Liu G, Zhou M, Zhang Z, et al
    First-in-Human Evaluation of [18F]AldoView: A Highly Selective PET Tracer for Aldosterone Synthase Imaging in Primary Aldosteronism.
    Clin Nucl Med. 2025 Jun 4. doi: 10.1097/RLU.0000000000006014.
    PubMed         Abstract available

  41. GARCIA-MEGIAS I, Cabada-Del Rio AM, Bonilla-Plaza JA, Cruz Montijano M, et al
    SPECT/CT as Gatekeeper for Extrathecal Administration on 99mTc-DTPA Cisternography.
    Clin Nucl Med. 2025 Jun 4. doi: 10.1097/RLU.0000000000006009.
    PubMed         Abstract available


    IEEE Trans Med Imaging

  42. WEBBER G, Mizuno Y, Howes OD, Hammers A, et al
    Likelihood-Scheduled Score-Based Generative Modeling for Fully 3D PET Image Reconstruction.
    IEEE Trans Med Imaging. 2025;PP.
    PubMed         Abstract available


    J Nucl Med

  43. HACHEY JS, Viray TD, Matasci M, Ravazza D, et al
    Targeting Extra Domain A of Fibronectin to Improve Noninvasive Detection of Triple-Negative Breast Cancer.
    J Nucl Med. 2025 Apr 17:jnumed.124.268859. doi: 10.2967/jnumed.124.268859.
    PubMed         Abstract available

  44. KAYAL G, Roseland ME, Wang C, Fitzpatrick K, et al
    Multicycle Dosimetric Behavior and Dose-Effect Relationships in [(177)Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy.
    J Nucl Med. 2025;66:900-908.
    PubMed         Abstract available

  45. THACKERAY JT
    2024 SNMMI Highlights Lecture: Cardiovascular Sciences.
    J Nucl Med. 2025 Apr 24:jnumed.125.269988. doi: 10.2967/jnumed.125.269988.
    PubMed         Abstract available

  46. COOLS R, Vermeulen K, Vonck E, Baekelandt V, et al
    In Vivo Visualization and Quantification of Brain Heat Shock Protein 90 with [(11)C]HSP990 in Healthy Aging and Neurodegeneration.
    J Nucl Med. 2025;66:940-947.
    PubMed         Abstract available

  47. FRANCA VELO A, Giantini Larsen A, Humm JL, Zanzonico P, et al
    Determination of the Intralesional Distribution of Theranostic (124)I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma.
    J Nucl Med. 2025 Apr 30:jnumed.124.267995. doi: 10.2967/jnumed.124.267995.
    PubMed         Abstract available

  48. MANSUR A, McConathy JE, Stringer-Reasor E, Rocque G, et al
    Quantitative [(89)Zr]Zr-Trastuzumab PET and Diffusion- Weighted MRI for Characterization of Metastatic HER2-Positive Breast Cancer with PET/MRI.
    J Nucl Med. 2025 Jun 5:jnumed.124.268931. doi: 10.2967/jnumed.124.268931.
    PubMed         Abstract available

  49. GAFITA A, Schroeder JA, Ceci F, Oldan JD, et al
    Treatment Response Evaluation in Prostate Cancer Using PSMA PET/CT.
    J Nucl Med. 2025 Jun 5:jnumed.124.268071. doi: 10.2967/jnumed.124.268071.
    PubMed         Abstract available

  50. IAGARU A, Suarez JF, Behr S, Aggarwal R, et al
    Imaging Efficacy of [(18)F]CTT1057 PET for the Detection of PSMA-Positive Tumors Using Histopathology as Standard of Truth: Results from the GuideView Phase 2/3 Prospective Multicenter Study.
    J Nucl Med. 2025 Jun 5:jnumed.124.269007. doi: 10.2967/jnumed.124.269007.
    PubMed         Abstract available

  51. FANTI S, Robles Barba JJ, Behr S, Maurer T, et al
    Imaging Efficacy of [(18)F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective Multicenter Study.
    J Nucl Med. 2025 Jun 5:jnumed.124.269266. doi: 10.2967/jnumed.124.269266.
    PubMed         Abstract available


    Nucl Med Commun

  52. SINGHAL T, Singh P, Parida GK, Agrawal K, et al
    Leg-muscle perfusion reserve on 99mTc-MIBI stress-rest scintigraphy: the novel use of radionuclide imaging in assessing lower extremity functional capacity.
    Nucl Med Commun. 2025;46:599-604.
    PubMed         Abstract available

  53. KAPLAN I, Komek H, Can C, Kaya Ipek F, et al
    Effect of body composition parameters, including sarcopenia, myosteatosis, and adipose tissue, on overall survival of patients with mCRPC receiving 177 Lu-PSMA PRRT.
    Nucl Med Commun. 2025;46:592-598.
    PubMed         Abstract available

  54. DESOUZA K, Fessas P, Spurrell E, Papadimitraki E, et al
    The safety and clinical impact of ultra-low-dose FDG-PET imaging in pregnancy-associated breast cancer: the experience of a major tertiary oncology referral centre in the UK and suggested imaging protocol.
    Nucl Med Commun. 2025 Jun 4. doi: 10.1097/MNM.0000000000001997.
    PubMed         Abstract available

  55. MUTEVELIZADE G, Aydin N, Duran Can O, Teke O, et al
    Predicting clinical outcomes using 18F-FDG PET/CT-based radiomic features and machine learning algorithms in patients with esophageal cancer.
    Nucl Med Commun. 2025 Jun 4. doi: 10.1097/MNM.0000000000002003.
    PubMed         Abstract available

  56. LEITE E SILVA MH, Barbosa da Silva MA, Dos Santos DSR, Fagundes TC, et al
    PET for predicting chemoradiotherapy survival in cervical cancer: the search continues.
    Nucl Med Commun. 2025 Jun 5. doi: 10.1097/MNM.0000000000001999.
    PubMed         Abstract available

  57. WANG Y, Yang G, Yan W, Yu W, et al
    18 F-FAPI PET/CT in chronic liver disease: myocardial fibroblast activation and its correlates.
    Nucl Med Commun. 2025 Jun 5. doi: 10.1097/MNM.0000000000002002.
    PubMed         Abstract available

  58. MOHLAPHOLI MS, Doruyter A, Mix M, Trauernicht C, et al
    The use of simulations to study the effect of acquisition schemes and quantification methods using positron emission tomography: an 18F-Fallypride study.
    Nucl Med Commun. 2025 Jun 6. doi: 10.1097/MNM.0000000000001995.
    PubMed         Abstract available


    Phys Med Biol

  59. KANG HG, Tashima H, Wakizaka H, Akamatsu G, et al
    Development of an ultrasensitive small animal PET with 4-layer DOI detectors for sub-second dynamic rodent imaging.
    Phys Med Biol. 2025 Jun 4. doi: 10.1088/1361-6560.
    PubMed         Abstract available

  60. DAWSON RJ, Huesa-Berral C, Carter L, Beekman C, et al
    Dosimetrically coupled multiscale tetrahedral mesh models of human liver vasculature: implications for radiopharmaceutical dosimetry of both organ blood and parenchyma.
    Phys Med Biol. 2025 Jun 2. doi: 10.1088/1361-6560.
    PubMed         Abstract available


    PLoS One

  61. ROWAN C, Hanna C, Sajjad M, Yao R, et al
    Cocaine self-administration attenuates brain glucose metabolism and functional connectivity in rats.
    PLoS One. 2025;20:e0324522.
    PubMed         Abstract available


    Semin Nucl Med

  62. DELGADO BOLTON RC, Calapaqui Teran AK, Santiago Almeida L, Paez D, et al
    Fibroblast Activation Protein Inhibitor (FAPI) PET in Sarcoma: An Update and Future Perspective.
    Semin Nucl Med. 2025 Jun 1:S0001-2998(25)00060.
    PubMed         Abstract available

  63. MENA E, Lindenberg L, Herscovitch P, Sadowski SM, et al
    Advances in Endocrine Tumor PET Imaging Targeting CXCR4 and GLP-1.
    Semin Nucl Med. 2025 May 29:S0001-2998(25)00058.
    PubMed         Abstract available

  64. THIENTUNYAKIT T, Muangpaisan W, Minoshima S
    (18)F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in the Era of Antiamyloid Treatment.
    Semin Nucl Med. 2025 May 29:S0001-2998(25)00057.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.